COPENHAGEN, Denmark, Feb. 24, 2025 (GLOBE NEWSWIRE) -- SNIPR BIOME ApS ("SNIPR” or "the Company”), a clinical stage biotech company pioneering CRISPR-based therapies, today announces grant of patent ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results